Physician

Phanicharan Aditya Sistla, M.D.

According to 2025 Medicare claims, Phanicharan Sistla, M.D. (NPI: 1720427453) practices interventional cardiology in the Davenport-Moline-Rock Island, IA-IL market, with the plurality of this provider's patient population coming from Rock Island, IL. This provider's primary affiliated billing organization is CARDIOVASCULAR MEDICINE PLLC (NPI: 1982632907; TIN: 421085919) and primary practice location at 61265-7127. Sistla is affiliated with the IRCCO (ACO ID: A2619), Genesis Accountable Care Organization, LLC. (ACO ID: A4799), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Sistla's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,367 traditional Medicare patients, billed 5,252 HCPCS/CPT codes, and received $302,938 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,851 prescription claims across 305 beneficiaries totaling $269,941 in drug costs, led by Eliquis (Apixaban). 2018 DME data shows 24 claims. Open Payments data shows 19 records totaling $1,922. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $24,956 to $302,938. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $8,800 and ending at $269,941. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	110	297	$24,956
2017	304	644	$55,376
2018	153	386	$32,574
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	272	786	$47,909
2024	1,367	5,252	$302,938

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	28	72	$8,800
2016	59	166	$6,068
2017	62	198	$39,433
2018	35	107	$5,991
2019	17	63	$1,897
2020	21	65	$7,561
2021	41	79	$91,721
2022	97	261	$18,271
2023	111	282	$36,442
2024	305	1,851	$269,941

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	24	$1,045
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	211	278	$92
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	257	261	$69
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	138	189	$13
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	201	236	$10
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	816	1,076	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	122	5,772	$108,425
Entresto	Sacubitril/Valsartan	73	3,165	$70,407
Jardiance	Empagliflozin	38	1,680	$33,605
Brilinta	Ticagrelor	29	900	$13,594
Xarelto	Rivaroxaban	15	593	$10,997

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	19	$1,922	Penumbra, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Phanicharan Aditya Sistla, M.D.?

Tedicare shows public-source Medicare data for Phanicharan Aditya Sistla, M.D. (NPI 1720427453), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Phanicharan Aditya Sistla, M.D. have ACO affiliation data?

Phanicharan Aditya Sistla, M.D. is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619), Genesis Accountable Care Organization, LLC. (MSSP, ACO ID A4799), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Phanicharan Aditya Sistla, M.D.?

Phanicharan Aditya Sistla, M.D. is linked to CARDIOVASCULAR MEDICINE PLLC (billing NPI 1982632907) in the available physician profile data.

Does Phanicharan Aditya Sistla, M.D. have Open Payments data?

Phanicharan Aditya Sistla, M.D. has 19 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.